A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT

Clinical trial NCT03866109 · TERMINATED

Trial details

NCT number: NCT03866109
Sponsor: Genenta Science
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2019-03-05
Primary completion: 2026-05-27
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.